all doses of semaglutide marketed under the trade names Ozempic and Wegovy became listed as available on the FDAs Drug Shortage List as of October 30, 2024
Mechanism of phytoestrogens action in reproductive processes of mammals and birds
Other Ingredient: Microcrystalline cellulose, Food Glaze, Vegetable Steari Acid, Silica, Vegetable Magnesium Stearate
Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2